WebNov 18, 2024 · Open. Pfizer Inc. said a final analysis of clinical-trial data showed its Covid-19 vaccine was 95% effective, paving the way for the company to apply this week for the first U.S. regulatory ... WebNEW YORK, USA and MAINZ, Germany, March 17, 2024 – Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech) today announced that the …
Pfizer Inc. - Investor Relations - Financials - SEC Filings
WebNov 18, 2024 · BioNTech SE said their vaccine protected people of all ages and ethnicities, with no significant safety problems so far in a trial that includes almost 44,000 participants. WebSep 2, 2024 · The FDA will hold an advisory committee meeting later this month to discuss Pfizer and BioNTech's filing for approval of a third booster dose of their COVID-19 vaccine Comirnaty in people aged 16 ... tamarina build epic seven
SEC Filing BioNTech
WebBioNTech SE (/ b iː ˈ ɒ n t ɛ k / bee-ON-tek; or / b aɪ ˈ ɒ n t ɛ k / bye-ON-tek short for Biopharmaceutical New Technologies) is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases. It develops pharmaceutical candidates based on messenger … WebMar 30, 2024 · Form 20F Filing. March 30, 2024 ... BioNTech SE. An der Goldgrube 12. 55131 Mainz, Germany. T: +49 6131 9084-0. F: +49 6131 9084-2121. [email protected]. Company. About Research & Innovation Pipeline Manufacturing Careers Covid-19. Quick Links. Newsroom Investors Healthcare Professionals Connect. WebDec 1, 2024 · BERLIN— Pfizer Inc. partner BioNTech and U.S. drugmaker Moderna Inc. both applied for their coronavirus vaccines to be approved in the European Union, the EU’s chief medicines regulator said ... twu founders scholarship